Implication of regulatory networks of long noncoding RNA/circular RNA-miRNA-mRNA in diabetic cardiovascular diseases

Epigenomics. 2020 Nov;12(21):1929-1947. doi: 10.2217/epi-2020-0188. Epub 2020 Nov 27.

Abstract

Diabetic cardiovascular diseases (DCVDs) are the most common complications of diabetes mellitus and are considered to be one of the most important threats to global health and an economic burden. Long noncoding RNA (lncRNA), circular RNA (circRNA), and miRNA are a novel group of noncoding RNAs that are involved in the regulation of various pathophysiological processes, including DCVDs. Interestingly, both lncRNA and circRNA can act as competing endogenous RNA of miRNA, thereby regulating the expression of the target mRNA by decoying or sponging the miRNA. In this review, we focus on the mechanistic, pathological and functional roles of lncRNA/circRNA-miRNA-mRNA networks in DCVDs and further discuss the potential implications for early detection, therapeutic intervention and prognostic evaluation.

Keywords: cardiovascular diseases; circular RNA; competing endogenous RNA; diabetes; long noncoding RNA; microRNA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Cardiovascular Diseases / diagnosis
  • Cardiovascular Diseases / genetics*
  • Cardiovascular Diseases / therapy
  • Gene Expression Regulation
  • Gene Regulatory Networks*
  • Humans
  • MicroRNAs*
  • Prognosis
  • RNA, Circular*
  • RNA, Long Noncoding*
  • RNA, Messenger*

Substances

  • Biomarkers
  • MicroRNAs
  • RNA, Circular
  • RNA, Long Noncoding
  • RNA, Messenger